Ropivacaine freeze-dried powder and injection preparation in use for injection and preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING BOERDA BIO TECH DEV
- Publication Date
- 2005-06-15
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a pharmaceutical preparation, in particular to a ropivacaine freeze-dried powder injection and a preparation method. Background technique
[0002] Ropivacaine (ropivacaine) is a new type of long-acting amide local anesthetic listed by Astra Pharmaceuticals in 1996. In December 1998, ropivacaine hydrochloride injection was imported into China. Its pharmacological properties are low cardiotoxicity, more obvious separation of sensory block and motor block, and vasoconstriction, so no need to add epinephrine, and it has no obvious effect on uterine placental blood flow. Low concentrations of ropivacaine can effectively block sensory nerve transmission and have little effect on motor nerves. Therefore, this drug is especially suitable for postoperative analgesia and obstetric anesthesia. Judging from the clinical application of ropivacaine in recent years at home and abroad, newborns have good tolerance to this drug, and the motor ...